The Bob Harrington Show

 
 

The Bob Harrington Show

  • New Revascularization Guidelines: Key Points and Controversies   Bob Harrington interviews fellow cardiologist Jacqueline Tamis-Holland, vice chair of the recent ACC/AHA revascularization guidelines. She lets us inside the process and responds to the controversy.
  • COVID-19 and the Heart: Is Cardiology Ready?   Robert Harrington, MD, interviews Ziyad Al-Aly, MD, about his recent paper in Nature Medicine focused on the long-term cardiovascular effects of COVID-19.
  • COVID and CV Public Health Trials 2021   Trials on lowering salt consumption and treating hypertension in the community impressed Drs Harrington and Gibson in this discussion of the best public health research of 2021.
  • Top Cardiology Trials of 2021   Drs Harrington and Gibson provide their annual roundup of what they consider the key cardiovascular trials of 2021.
  • Meet the Doc Who Put Hydroxychloroquine on Trial in COVID-19   Drs Bob Harrington and Martin Landray discuss the importance of randomization for testing therapeutics and the opportunities the COVID-19 pandemic provided.
  • A Tale of Medical Mysteries Unraveled by Genetic Detectives   A genomics giant with a family history of heart disease and an Olympic athlete accused of cheating are just two of the medical mysteries that were unraveled by DNA analysis.
  • COVID and the Athlete's Heart   When is it safe to return to play after having COVID? Bob Harrington and Manesh Patel discuss our evolving understanding of how SARS-CoV-2 affects the hearts of athletes and weekend warriors.
  • 2020 Wrap-up: COVID-19's Effects on Cardiology   Bob Harrington and Mike Gibson continue their review of 2020, discussing the 'riddle wrapped in an enigma' that was the COVID-19 pandemic.
  • Top Cardiology Trials of 2020 in Review   The annual tradition continues as did cardiology research despite a pandemic. Trials on fish oils, statins, SGLT2 inhibitors, and antiplatelets are among the selections of Drs Harrington and Gibson.
  • Pandemic Publishing: Speed vs Quality Control   Three editors of cardiology journals -- Drs Harrington, Yancy, and Nallamothu -- discuss the challenges of maintaining quality during the COVID-19 surge in submissions.
  • Thrombosis in COVID-19: What We Know and How to Treat   Hematologist Mary Cushman discusses arterial and venous thrombosis issues with SARS-CoV-2 and the role of anticoagulation.
  • Pandemic: 'Another Earthquake' Exposing Health Inequities   Bob Harrington asks Michelle Albert why mortality rates are so high in minority communities, and whether COVID-19 will lead to meaningful changes in health and social inequities.
  • Yes, There Is a Role for Poetry and Fiction in a Pandemic   'They fancy themselves free. And no one will ever be free so long as there are pestilences,' wrote Camus in 'The Plague', which Abraham Verghese sees as relevant to our collective experience of COVID-19.
  • A Cardiologist's Search for Medicine's Lost Heart   Cardiologist Lisa Rosenbaum seeks meaning in her work as a physician and correspondent for the New England Journal of Medicine, a quest first started by her grandfather who was also a physician-writer.
  • Cardiology's Hottest Trial of 2019 and Healthcare 2020   Bob Harrington and Mike Gibson continue their review of 2019 with the 'hottest trial of the year' and what to expect in healthcare in 2020.
  • Cardiology 2019: Top Trials in Review   'It's like we're in the '90s again.' Drs Gibson and Harrington review top cardiology trials on revascularization, lipid management, and antithrombotics in part 1 of their annual wrap-up.
  • How a Snakebite and Sudden Death Led to Cardiology and Writing   A family history of sudden death was the impetus for author Sandeep Jauhar's fascination with the heart, which led to a career in cardiology and his latest book Heart: A History.
  • 'I Was That Kid': Dr Quinn Capers Inspires #BlackMenInMedicine   Fewer black men are going into medicine today than in 1978. Drs Harrington and Capers discuss how to increase diversity in medicine and why it's important for caregivers to reflect the population they treat.
  • Calling Time on the Failure in Heart Failure   Optimal medical therapy and recent advances show that heart failure is preventable and not obligatory, Clyde Yancy tells Bob Harrington.
  • Cardiology Topics to Watch for in 2019 Wearables, aspirin for secondary prevention, AI and machine learning, and drug pricing are among the topics to keep an eye on in 2019, according to cardiologists Drs Harrington and Gibson.